The Chinese Pharmaceutical Journal最新文献

筛选
英文 中文
Synthesis of Mustard-Derived and Heteroaromatic Combretastatin Analogues(superscript #) 芥菜衍生及杂芳香族复合抑素类似物的合成(上标#)
The Chinese Pharmaceutical Journal Pub Date : 2007-12-01 DOI: 10.7019/TPJ.200712.0195
Guan-Hon Chern, Ming‐Kuan Hu
{"title":"Synthesis of Mustard-Derived and Heteroaromatic Combretastatin Analogues(superscript #)","authors":"Guan-Hon Chern, Ming‐Kuan Hu","doi":"10.7019/TPJ.200712.0195","DOIUrl":"https://doi.org/10.7019/TPJ.200712.0195","url":null,"abstract":"The aim of this study was to delicately synthesize certain hybrid molecules bearing the mustard-derived and/or heterocyclic combretastain analogues to exploit new antitumor agents. Thus, a variety of heteroaromatic combretastatin analogues 8a-e were efficiently prepared and readily accessed to nitrogen mustard through an ester linkage. However, these delicately hybrid compounds were only shown moderate growth inhibitory potency with most IC50s at micromolar levels, which were much less potent than the natural CA-4 against the KB cells.","PeriodicalId":22409,"journal":{"name":"The Chinese Pharmaceutical Journal","volume":"15 1","pages":"195-202"},"PeriodicalIF":0.0,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82641785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thermal and Photooxidation Reactions of the Steroids : β-Sitosterol, Stigmasterol and Diosgenin 甾体的热和光氧化反应:β-谷甾醇、豆甾醇和薯蓣皂苷元
The Chinese Pharmaceutical Journal Pub Date : 2007-09-01 DOI: 10.7019/TPJ.200709.0113
E. Elgendy, Huda Al-Ghamdy
{"title":"Thermal and Photooxidation Reactions of the Steroids : β-Sitosterol, Stigmasterol and Diosgenin","authors":"E. Elgendy, Huda Al-Ghamdy","doi":"10.7019/TPJ.200709.0113","DOIUrl":"https://doi.org/10.7019/TPJ.200709.0113","url":null,"abstract":"Phytosterols β-sitosterol (1) and stigmasterol (2) were extracted from Nigella sativa which were collected from Al Qaseem’s area in the Kingdom of Saudi Arabia. Steroidal sapogenin diosgenin (3) was extracted from Balanites aegyptiaca (Zygopyllaceae), which was collected from Khamis al Bahr in theKingdom of Saudi Arabia. They have been fully characterized. Stigmasterol (2) and diosgenin (3) were acetylated to give stigmasterol and diosgenin acetate derivatives 4 and 5. Epoxidation of 1-5 gave exo and endo epoxide derivatives 6a, b; 10a, b; 11a, b; 16a, b and 17a, b as precursors of the brassinosteroidal compounds. On the other hand, photooxygenation of 1-5 gave hydroperoxysitosterol derivatives 7 and 9, hydroperoxystigmasterol derivatives 12 and 13, hydroperoxystigmasterol acetate derivatives 14 and 15, hydroperoxydiosgenin derivatives 18 and 19, and hydroperoxydiosgenin acetate derivatives 20 and 21.","PeriodicalId":22409,"journal":{"name":"The Chinese Pharmaceutical Journal","volume":"1 1","pages":"113-132"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78527876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Quantification of Plasmid DNA in pCA-HA/poly-L-lysine Complex pCA-HA/聚l -赖氨酸复合物质粒DNA的定量分析
The Chinese Pharmaceutical Journal Pub Date : 2007-09-01 DOI: 10.7019/TPJ.200709.0133
Chien-Lung Hsu, Cheng-Wei Chen, Bo Zheng, Jii Chen, Tianhui Zhou
{"title":"Quantification of Plasmid DNA in pCA-HA/poly-L-lysine Complex","authors":"Chien-Lung Hsu, Cheng-Wei Chen, Bo Zheng, Jii Chen, Tianhui Zhou","doi":"10.7019/TPJ.200709.0133","DOIUrl":"https://doi.org/10.7019/TPJ.200709.0133","url":null,"abstract":"This report describes the comparison of four pDNA quantitative methods including UV/Visible spectro-photometry, agarose gel electrophoresis, EtBr staining fluoro-photometry and HPLCSEC method. Finally, the HPLC-SEC method was used to evaluate the interaction of plasmid DNA (pCA-HA) and poly-L-lysine (PLL). In the pCA-HA concentrations ranged form 3.125 to 50 μg/mL, the standard curve of pCA-HA has good linearity, accuracy (CV%<3%) and precision (Error%<4%) by using UV/Visible spectro-photometry. But the sensitivity is not enough to evaluate less than 3 μg/mL of pDNA. The intensity of fluorescene emission of EtBr stained pCA-HA is not dose dependent by using EtBr staining fluoro-photometry. The agarose gel electrophoresis had a high sensitivity (ng/mL level), but the accuracy (CV%>15%) and precision (Error%>15%) were not good in the range of 0.048~0.760 μg/mL pCA-HA. The standard curve of pCA-HA had good linearity, accuracy (CV%<3%) and precision (Error%<5%) in the pCA-HA concentration ranges from 0.4 to 1.2 μg/mL by using the HPLC-SEC method. PLL, a positive charged peptide, was used to condense DNA and enhance the transfection of DNA in cell. We used the HPLC-SEC method to evaluate the interaction of pDNA and PLL. When the charge of pCA-HA and PLL were almost the same, the peak of pDNA disappeared from the HPLC chromatogram. It means that the charge ratio of pCA-HA/PLL is close to 1 in the complex.","PeriodicalId":22409,"journal":{"name":"The Chinese Pharmaceutical Journal","volume":"24 1","pages":"133-140"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87133105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-inflammatory Activity and Structure-activity Relationships of 2-Hydroxy-N-(alkylphenyl) Nicotinamides 2-羟基- n -(烷基苯基)烟酰胺的抗炎活性及构效关系
The Chinese Pharmaceutical Journal Pub Date : 2007-09-01 DOI: 10.7019/TPJ.200709.0105
Chien-Ming Huang, Y. Hsieh, Wen‐Hsin Huang, A. Lee
{"title":"Anti-inflammatory Activity and Structure-activity Relationships of 2-Hydroxy-N-(alkylphenyl) Nicotinamides","authors":"Chien-Ming Huang, Y. Hsieh, Wen‐Hsin Huang, A. Lee","doi":"10.7019/TPJ.200709.0105","DOIUrl":"https://doi.org/10.7019/TPJ.200709.0105","url":null,"abstract":"Leflunomide 1 and its non-enzymically active metabolite, malononitrilamide (MNA, 2) are clinical use for treating rheumatoid arthritis (RA). Study indicated that the active pharmacophore, a β-keto amide with the enolic hydroxyl group, was fully responsible for the immunosuppressive effects of malononitrilamide 2 leading a salicylamide derivative 3 developed. Previously, we have conducted isosterically structural modification mainly based on salicylamide derivative 3, which β-hydroxy-enamide-containing portion remains untouched, to successfully synthesize a series of 2-hydroxy-N-(4-substituted phenyl)nicotinamides. After pharmacological screenings, compounds bearing electron-withdrawing groups such as 4-Cl, 4-Br, and 4-NO2 significantly showed potent anti-inflammatory activity. 1 Currently, a series of compounds 5-13, which are alkyl substitution on phenylmoiety, mainly based on 2-hydroxy-N-(phenyl)nicotinamide 4 were further synthesized in high yields. After systematic pharmacological screenings of compounds 5-13, all compounds exhibited less potent anti-inflammatory activity comparable to leflunomide 1 and malononitrilamide 2 by both in vitro suppressing nitric oxide (NO) production under the LPS-elicited macrophage Raw 264.7 cell and the in-vivo carrageenan-induced paw edema assay.","PeriodicalId":22409,"journal":{"name":"The Chinese Pharmaceutical Journal","volume":"1 1","pages":"105-112"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90060280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Simple and Rapid Liquid Chromatographic Method for Determination of Histidine HCl in Pharmaceutical Preparations 快速液相色谱法测定药物制剂中组氨酸HCl的含量
The Chinese Pharmaceutical Journal Pub Date : 2007-09-01 DOI: 10.7019/TPJ.200709.0141
Pochuen Shieh, Su-Shiang Cheng, D. Kuo, Wenyan Fu, M. Hsu, Fu-An Chen
{"title":"Simple and Rapid Liquid Chromatographic Method for Determination of Histidine HCl in Pharmaceutical Preparations","authors":"Pochuen Shieh, Su-Shiang Cheng, D. Kuo, Wenyan Fu, M. Hsu, Fu-An Chen","doi":"10.7019/TPJ.200709.0141","DOIUrl":"https://doi.org/10.7019/TPJ.200709.0141","url":null,"abstract":"Histidine (HID) is frequently compounded in pharmaceutical preparations for the treatment of gastrointestinal diseases. A simple and rapid liquid chromatographic method was developed and validated for the routine determination of HID in pharmaceutical preparations. The high-performance liquid chromatographic (HPLC) system consisted of an Purospher STAR RP18 endcapped column (4.6×250 mmi. d.) using amobile phase of 50 mMphosphate buffer with 3 mM sodium octanesulfonate: acetonitrile (95:5, v/v) with an ultraviolet/visible (UV/VIS) detector at 210 nm. The developed method satisfies the system suitability criteria and peak integrity for HID. The square of the correlation coefficient of the linear regression analysis was 0.9995. The relative standard deviations (RSDs) for intra- and inter-day tests were less than 2%. The recovery for 5 concentrations expressed as the closeness of the observed mean to the spiked concentration was 98.20%~101.02%. The limits of detection (LOD) and quantitation (LOQ) for HID were 2.2 and 7.3 μg/mL, respectively. The method was applied to quantitatively determine HID in 8 brands of HID-containing tablets on the Taiwanese market, and these were found to contain 100.59%±1.01% of the percentage claimed on the label. The results indicate that the established assay method is suitable for measuring HID in pharmaceutical preparations.","PeriodicalId":22409,"journal":{"name":"The Chinese Pharmaceutical Journal","volume":"25 4 1","pages":"141-148"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86054221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antiplatelet Effect of Leonurine from Leonurus sibiricus 益母草尿的抗血小板作用
The Chinese Pharmaceutical Journal Pub Date : 2007-09-01 DOI: 10.7019/TPJ.200709.0149
Hang-Ching Lin, Sheng-Ming Pan, H. Ding, T. Chou, Wen-liang Chang
{"title":"Antiplatelet Effect of Leonurine from Leonurus sibiricus","authors":"Hang-Ching Lin, Sheng-Ming Pan, H. Ding, T. Chou, Wen-liang Chang","doi":"10.7019/TPJ.200709.0149","DOIUrl":"https://doi.org/10.7019/TPJ.200709.0149","url":null,"abstract":"Leonurine (1) was simply isolated from the aerial part of Leonurus sibircus var. albiflora. Their structures were established on the basis of spectral evidence. Leonurine showed a significant inhibited rabbit platelet aggregation induced by thrombin, arachidonic acid, and collagen in vitro with an IC50 of 97.22 μM, 31.03 μM, and 44.48 μM, respectively.","PeriodicalId":22409,"journal":{"name":"The Chinese Pharmaceutical Journal","volume":"2 1","pages":"149-152"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88810502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Hepatic in Vitro Metabolism of Etoperidone, an Antidepressant Drug, in the Rat and Human 抗抑郁药物依哌啶酮在大鼠和人体内肝脏体外代谢的研究
The Chinese Pharmaceutical Journal Pub Date : 2007-02-01 DOI: 10.7019/CPJ.200702.0031
W. Wu, L. A. Mckown
{"title":"Hepatic in Vitro Metabolism of Etoperidone, an Antidepressant Drug, in the Rat and Human","authors":"W. Wu, L. A. Mckown","doi":"10.7019/CPJ.200702.0031","DOIUrl":"https://doi.org/10.7019/CPJ.200702.0031","url":null,"abstract":"The in vitro metabolism of etoperidone (Et), an antidepressant drug, was conducted after 30 and 60 min incubations with rat hepatic S9 fraction, and 60 and 90 min incubations with human hepatic S9 fraction, respectively, in the presence of an NADPH-generating system. Unchanged Et (35% of the sample in rat, 46% in human) plus 8 phase I metabolites from the 60 min rat incubation, and 9 phase I metabolites from the 90 min human incubation, were profiled, quantified, and tentatively identified on the basis of API-MS and MS/MS data. The formation of Et metaboiltes are via the following three metabolic pathways: 1. alkyl oxidation, 2. phenyl oxidation, and 3. oxidative N-dealkylation, Pathways 1 and 2 formed 2 major metabolites [OH-ethyl Et (M1): 18-21% of the sample; OH-Ph Et (M2): 14-32%] and 3 minor metabolites [oxo-ethyl Et (M3): 1-3%; OH-ethyl-OH-Ph Et (M4): 3-5%; oxo-ethyl-OH-Ph Et (M5): 1-3%] in all species, and pathway 3 in conjunction with phenyl oxidation led to the production of 3 minor metabolites, triazole propyl aldehyde (M6), triazole propionic acid (M7) and OH-Ph-MCPP (M9) with each ≤ 1-2% of the sample, and a moderate metabolite, MCPP (M8, 1-8%) in all species. In general, both rat and human appeared to metabolize Et extensively in this hepatic system.","PeriodicalId":22409,"journal":{"name":"The Chinese Pharmaceutical Journal","volume":"44 26","pages":"31-38"},"PeriodicalIF":0.0,"publicationDate":"2007-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91538969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Synthesis of N-(chlorophenyl ) -2 -hydroxynicotinanilides as potential anti-inflammatory agents 作为潜在抗炎剂的N-(氯苯基)-2 -羟基烟酰苯胺的合成
The Chinese Pharmaceutical Journal Pub Date : 2007-02-01 DOI: 10.7019/CPJ.200702.0039
Chien-Ming Huang, Y. Hsieh, Wen‐Hsin Huang, A. Lee
{"title":"Synthesis of N-(chlorophenyl ) -2 -hydroxynicotinanilides as potential anti-inflammatory agents","authors":"Chien-Ming Huang, Y. Hsieh, Wen‐Hsin Huang, A. Lee","doi":"10.7019/CPJ.200702.0039","DOIUrl":"https://doi.org/10.7019/CPJ.200702.0039","url":null,"abstract":"Leflunomide 1 and its non-enzymically active metabolite, malononitrilamide (MNA, 2) are clinical use for treating rheumatoid arthritis (RA). Study indicated that the active pharmacophore, a β-keto amide with the enolic hydroxyl group, was fully responsible for the immunosuppressive effects of malononitrilamide 2 leading a salicylamide derivative 3 developed. Previously, we have conducted isosterically structural modification mainly based on salicylamide derivative 3, which β-hydroxy-enamide-containing portion remains untouched, to successfully synthesize a series of N-(4-substituted phenyl)-2-hydroxynicotinanilides. After pharmacological screenings, compounds bearing electron-withdrawing groups such as 4-Cl, 4-Br, and 4-NO2 significantly showed potent anti-inflammatory activity. Currently, a series of compounds 5-14, which are the chloro variants on phenyl moiety, mainly based on N-(substituted phenyl)-2-hydroxynicotin-anilide 4-14 were further synthesized in high yields. After systematic pharmacological screenings of compounds 4-14 and controls, compound 14 exhibited potent in-vivo anti-inflammatory activity comparable to that of compound 5 and Leflunomide 1, whereas the other compounds have comparable activity to compound 4 and malononitrilamide 2 by both in vitro suppressing nitric oxide (NO) production under the LPS-elicited macrophage Raw 264.7 cell and the in-vivo carrageenaninduced paw edema assay, except for compounds 8 and 11.","PeriodicalId":22409,"journal":{"name":"The Chinese Pharmaceutical Journal","volume":"26 1","pages":"39-45"},"PeriodicalIF":0.0,"publicationDate":"2007-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89573764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Nephrotoxicity of Vancomycin and Teicoplanin Alone and in Combination with an Aminoglycoside 万古霉素和替柯planin单独及与氨基糖苷联合的肾毒性
The Chinese Pharmaceutical Journal Pub Date : 2007-02-01 DOI: 10.7019/CPJ.200702.0001
Li-Ying Huang, Chun-yu Wang, T. Jang, Hseng-Long Yeh
{"title":"Nephrotoxicity of Vancomycin and Teicoplanin Alone and in Combination with an Aminoglycoside","authors":"Li-Ying Huang, Chun-yu Wang, T. Jang, Hseng-Long Yeh","doi":"10.7019/CPJ.200702.0001","DOIUrl":"https://doi.org/10.7019/CPJ.200702.0001","url":null,"abstract":"Background and Purpose: Vancomycin and teicoplanin are considered first line medications for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections but these agents are also associated with the side-effect of nephrotoxicity. This study investigated the association between treatment with vancomycin monotherapy, teicoplanin monotherapy and combinations of these drugs with aminoglycoside antibiotics, and the occurrence of nephrotoxicity. Methods: Patients treated with vancomycin or teicoplanin, either alone or in combination with an aminoglycoside antibiotic from June to December 2003 were included. Data analyzed included age, gender, renal function (before and after drug administration), days of antibiotics administration, location of infection, other antibiotics used in combination factors affecting renal function. Results: A total of 96 patients, comprising 50 males and 46 females, with a mean age of 67.97±13.43 years were included. Multivariate logistic regression analysis revealed no association between treatment with vancomycin or teicoplanin and gender, chronic renal function impairment, dialysis treatment, diabetes, hypertension, mean age, combination with an aminoglycoside, or treatment in the ICU. Among the 28 courses of vancomycin treatment for which there were adequate serum concentration monitoring data, 16 (57.1%) courses resulted in high trough vancomycin concentration, 8 (28.6%) courses were in the normal range, and 4 (14.3%) courses were low trough concentration. Vancomycin trough serum concentrations were significantly higher in ICU patients (p=0.003). Conclusion: There was no significant difference (p>0.05) in nephrotoxicity among patients treated with vancomycin or teicoplanin alone or in combination with an aminoglycoside. Vancomycin trough serum concentrations were highest in critically ill patients. Additional serum concentration monitoring in ICU patients was therefore advised after the use of vancomycin, in order to make necessary dosage adjustment. This can avoid unnecessary drug expenditure and reduce the likelihood of side-effects.","PeriodicalId":22409,"journal":{"name":"The Chinese Pharmaceutical Journal","volume":"12 1","pages":"1-8"},"PeriodicalIF":0.0,"publicationDate":"2007-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84820493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Preparation and In-vitro Characterization of Tizanidine Controlled-Release Microcapsular Matrices 替扎尼定控释微胶囊基质的制备及体外表征
The Chinese Pharmaceutical Journal Pub Date : 2007-02-01 DOI: 10.7019/CPJ.200702.0017
K. Dashora, S. Saraf, S. Saraf
{"title":"Preparation and In-vitro Characterization of Tizanidine Controlled-Release Microcapsular Matrices","authors":"K. Dashora, S. Saraf, S. Saraf","doi":"10.7019/CPJ.200702.0017","DOIUrl":"https://doi.org/10.7019/CPJ.200702.0017","url":null,"abstract":"Oral microencapsulated controlled release preparations of tizanidine hydrochloride (TIZ) were prepared by modified solvent evaporation technique using different proportions of ethyl cellulose as the retardant material. The microcapsules (TIZ1, TIZ2 and TIZ3) were compressed in to tablets (T-TIZ1, T-TIZ2 and T-TIZ3) for oral delivery. The prepared microcapsules were white, free flowing and spherical in shape, with the particle size varying from 215.38 ± 11.52 to 227.36 ± 12.89 μm and shows good drug entrapment efficiency. The 60% of TI2 release from microcapsules were found to be 2.15 ± 0.6, 2.98 ± 0.6 and 4.55 ± 0.8 h respectively for formulation TIZ1, TIZ2 and TIZ3 while their tablets i.e., T-TIZ1, T-TIZ2 and T-TIZ3 releases in 7.49 ± 1.2, 8.69 ± 0.6 and 15.24 ± 0.3 h respectively indicating more extension of time in tablet than microcapsules. The mechanism of drug release from tizanidine hydrochloride microcapsules and their tablets were studied by using Higuchi and Korsmeyer-Peppas models. The r-value for TIZ1, TIZ2 and TIZ3 indicates diffusion controlled with first order kinetic. The value of exponent coefficient (n) for T-TIZ1, T-TIZ2 and T-TIZ3 were found to be 0.874, 0.902 and 0.913 indicating anamolous, case-Ⅱ and case-Ⅱ transport release mechanism respectively.","PeriodicalId":22409,"journal":{"name":"The Chinese Pharmaceutical Journal","volume":"14 1","pages":"17-24"},"PeriodicalIF":0.0,"publicationDate":"2007-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76193534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信